BAINBRIDGE ISLAND, Wash. - Oct. 15, 2026 - Solius Labs, the world’s only Personalized Sunlight company, today announced that Solius Pro, the first FDA-cleared personalized UVB light therapy device, earned a TIME Best Inventions 2026 Special Mention in the Health & Wellness category. The annual list honors inventions that are exceptional products, services, and scientific or technological breakthroughs that are reshaping industries, solving global challenges, and improving everyday life.
Solius Pro leverages the company’s patent-pending skin analysis system to measure each individual’s skin tone and calculate a precise, personalized dose of UVB light. It delivers the benefits of natural sunlight in a few minutes per week with 99% less UV risk than the sun. The device is engineered to deliver 12 times the UVB benefit of natural sunlight per minute, and in a clinical trial, users’ serum vitamin D levels rose by an average of 76% (10.2 ng/mL).
The health benefits of UVB light go well beyond stimulating the production of vitamin D. A growing body of research links UVB exposure to benefits throughout the body, including bone health, immune function, mood, hormonal balance, cardiovascular health, and the gut microbiome. Solius Pro was built to deliver UVB light safely, precisely, and year-round.
“Being recognized by TIME is a huge honor for the Solius team and for the field of light medicine,” said Chris Kiple, Chief Executive Officer of Solius Labs. “Therapeutic UVB light has been studied for decades in hospitals and research labs. Our mission at Solius is to make it accessible to everyone and to personalize each UVB dose to an individual’s skin tone for safe and effective therapy.”
This recognition from TIME, coupled with the recent naming to Fast Company’s Next Big Things in Tech in the Wellness and Fitness category, underscores growing momentum for personalized UVB light therapy as a new category of medical device. Solius was also named a 2026 Digital Health Awards Quarterfinalist in the Healthy Lifespan, Longevity, and Prevention category.
Solius Pro’s development and clinical research are supported by the Solius Scientific and Medical Advisory Board, a group of independent experts who advise on clinical research and provide scientific and medical insight into the safety, effectiveness, and appropriate use of Solius technology.
About Solius Labs
Solius Labs is the world’s first Personalized Sunlight company, developing FDA-cleared, medical-grade UVB light therapy technologies that safely replicate the systemic biological benefits of sunlight year-round. By combining a targeted UVB spectrum, personalized dosing, and clinical validation, Solius is redefining how UVB light is used to support human health. For more information, visit Solius.com.
Press Contact
media@solius.com
